B

BBP

Virtus LifeSci Biotech Products ETF

86.2 6 USD

-1.23%

Сектор: Финансы

Базовая: USD

Валюта прибыли: USD

Дневной диапазон

Годовой диапазон

Дневное изменение

-1.23%

Месячное изменение

+2.41%

6-месячное изменение

+9.58%

Годовое изменение

+53.38%

Предыдущее закрытие

87.3 3

Open

86.2 6

Low

86.2 6

High

86.2 6

Volume

1

Открыть полный график Full chart

Обзор Все активы Тепловая карта

Ключевые активы Market Value Shares Weight %

TBPH THERAVANCE BIOPHARMA INC 712.4 K 37.6 K 1.6%

VRTX VERTEX PHARMACEUTICALS INC 710.0 K 1 511.0 1.6%

BIIB BIOGEN INC 705.7 K 3 923.0 1.6%

BBIO Bridgebio Pharma Inc 702.6 K 9 093.0 1.6%

Ascendis Pharma A/S 700.9 K 3 100.0 1.6%

IONS IONIS PHARMACEUTICALS INC 698.9 K 8 454.0 1.6%

LGND LIGAND PHARMACEUTICALS 692.5 K 3 605.0 1.5%

EXEL EXELIXIS INC 691.4 K 16.7 K 1.5%

GERN Geron Corp 688.4 K 502.5 K 1.5%

AGIO AGIOS PHARMACEUTICALS INC 687.6 K 25.1 K 1.5%

REGN REGENERON PHARMACEUTICALS 682.9 K 921.0 1.5%

PTCT PTC Therapeutics Inc 682.3 K 9 033.0 1.5%

SNDX Syndax Pharmaceuticals Inc 681.4 K 33.5 K 1.5%

CRNX Crinetics Pharmaceuticals Inc 675.9 K 13.5 K 1.5%

ARWR Arrowhead Pharmaceuticals Inc 675.9 K 9 749.0 1.5%

ROIV Roivant Sciences Ltd 668.5 K 30.9 K 1.5%

UTHR UNITED THERAPEUTICS CORP 648.8 K 1 382.0 1.4%

SRPT SAREPTA THERAPEUTICS INC 645.6 K 31.7 K 1.4%

PHAT Phathom Pharmaceuticals Inc 641.6 K 46.9 K 1.4%

TGTX TG Therapeutics Inc 641.5 K 21.8 K 1.4%

1
2
3
4

Новости

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)